KR100466379B1 - Composition for skin whitening - Google Patents

Composition for skin whitening Download PDF

Info

Publication number
KR100466379B1
KR100466379B1 KR1019970066969A KR19970066969A KR100466379B1 KR 100466379 B1 KR100466379 B1 KR 100466379B1 KR 1019970066969 A KR1019970066969 A KR 1019970066969A KR 19970066969 A KR19970066969 A KR 19970066969A KR 100466379 B1 KR100466379 B1 KR 100466379B1
Authority
KR
South Korea
Prior art keywords
extract
skin
whitening
skin whitening
composition
Prior art date
Application number
KR1019970066969A
Other languages
Korean (ko)
Other versions
KR19990048306A (en
Inventor
이종태
진무현
김송이
김청택
김호정
윤정미
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1019970066969A priority Critical patent/KR100466379B1/en
Publication of KR19990048306A publication Critical patent/KR19990048306A/en
Application granted granted Critical
Publication of KR100466379B1 publication Critical patent/KR100466379B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

본 발명은 피부미백용 조성물에 관한 것으로, 백질려 추출물이 유효성분으로 포함되어 피부에 부작용이 없고 피부미백효과가 우수한 피부외용연고나 각종 화장료로 제형가능한 것이다.The present invention relates to a composition for skin whitening, containing the extract of white bran as an active ingredient and having no side effects on the skin and having excellent skin whitening effect, which can be formulated as an external skin ointment or various cosmetics.

Description

피부미백용 조성물{Composition for skin whitening}Composition for skin whitening

본 발명은 피부비백용 조성물에 관한 것으로, 특히 기미나 주근깨 개선 및 피부미백용으로 연고나 각종 화장료로 제형이 가능한 멜라닌 생성 억제 효과가 우수한 백질려 추출물을 유효성분으로 하는 피부미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening, and more particularly, to a composition for skin whitening, which has an effect of inhibiting melanin production, which can be formulated as an ointment or various cosmetics for improving blemishes and freckles and skin whitening, as an active ingredient. .

일반적으로 희고 고운 피부를 갖고자 하는 것은 모든 사람의 한결같은 바램이나, 사람의 피부색은 피부내 멜라닌의농도와 분포에 따라 유전적으로 결정되고, 태양 자외선이나 피로, 스트레스 등의환경적 또는 생리적 조건에 의해서도 영향을 받아 각 개인별 피부색 차이를 갖게 된다. 멜라닌은 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다.In general, the desire to have white and fair skin is the constant desire of everyone, but the color of a person's skin is genetically determined by the concentration and distribution of melanin in the skin, and also by environmental or physiological conditions such as sun ultraviolet rays, fatigue and stress. It is affected by the color difference of each individual. Melanin is a type of amino acid tyrosine (tyrosinase) acts as an enzyme called tyrosinase (tyrosinase) is converted to dopa (DOPA), dopaquinone (dopaquinone) is produced through a non-enzymatic oxidation reaction.

이와 같이 멜라닌이 만들어지는 경로는 알려져 있으나, 티로시나제가 작용하는 이전 단계인 멜라닌 합성을 유도하는 메카니즘이 무엇인지에 대해서는 아직도 자세히 밝혀지지 않고 있다.As such, the pathway by which melanin is produced is known, but the mechanisms that induce melanin synthesis, the previous stages of tyrosinase action, are still unknown.

따라서 희고 고운 피부를 갖게 하기 위해 하이드로퀴논이나 아스콜빈산, 고지산, 글루타치온 등과 같은 티로시나제에 저해 활성을 갖는 물질을 연고나 화장료에 배합하여, 피부 미백이나 기미, 주근깨 개선의 목적에 사용하여 왔다.Therefore, in order to have white and fair skin, substances having inhibitory activity against tyrosinase, such as hydroquinone, ascorbic acid, high acid, glutathione, and the like, have been used in ointments or cosmetics for the purpose of improving skin whitening, blemishes and freckles.

그러나 이들은 피부에 자극을 유발하거나 제품 안정성이 좋지 못하여 사용이 제한되고, 또한 그 효과도 미약한 단점이 있었다.However, they cause skin irritation or poor product stability, which limits their use, and also has a weak effect.

이에 본 발명은 상기한 단점을 해소하기 위한 것으로, 피부에 무해하고 피부미백효과가 우수한 피부미백용 조성물을 제공함에 그 목적이 있다.Accordingly, the present invention is to solve the above-mentioned disadvantages, the object of the present invention is to provide a skin whitening composition that is harmless to the skin and excellent skin whitening effect.

상기한 목적을 달성하기 위한 본 발명의 피부미백용 조성물은 백질려 추출물을 유효성분으로 하는 것이다.Skin whitening composition of the present invention for achieving the above object is to make the whitening extract as an active ingredient.

상기 피부미백용 조성물에서 상기 백질려 추출물이 건조 중량으로 0.001~10.0중량% 함유된 것이 피부미백효과를 잘 나타낼 수 있어 바람직하다.The whitening composition in the skin whitening composition is preferably contained in 0.001 ~ 10.0% by weight of dry weight can exhibit a good skin whitening effect.

이하 본 발명의 구성 및 작용을 상세하게 설명한다.Hereinafter, the configuration and operation of the present invention will be described in detail.

상기한 바와 같이 본 발명의 피부미백용 조성물은 백질려 추출물을 유효성분으로 하는 것으로, 본 발명은 상기 백질려 추출물이 피부미백효과를 가짐을 처음으로 발견하여 이를 피부미백용 조성물에 적용한 것이다.As described above, the composition for skin whitening of the present invention is to have the whitening extract as an active ingredient, and the present invention is the first to find that the whitening extract has a skin whitening effect and apply it to the composition for skin whitening.

즉, 본 발명자들이 멜라닌 합성 유도 자체를 억제하는 물질까지 스크리닝할 수 있는 쥐의 멜라노마 세포(B16 mouse melanoma cell)를 이용하여 천연에서 자생하는 동식물들을 대상으로 새로운 미백제를 개발하고자 연구를 거듭한 결과, 상기 백질려 추출물에 매우 강력한 멜라닌 생성 억제 효과와 미백 효과가 있음을 발견하고, 이를 피부미백용 조성물에 적용한 것이다.In other words, the present inventors conducted a study to develop a new whitening agent for native plants and animals using B16 mouse melanoma cells that can screen a substance that inhibits melanin synthesis induction itself , It is found that the whitening extract has a very strong melanin inhibitory effect and whitening effect, it was applied to the skin whitening composition.

상기 백질려는 자질려라고도 불리며 일련싱 초본인 질려의 과실로 그 라틴명은 Fructus trubuli이다. 백질려의 기원식물인 질려는 남가새과(Zygophyllaceae)에 속하며 학명은 Trubulus terrestris L.이다. 백질려는 전통적으로 두통현훈(頭痛眩暈), 목시다루(目示多淚), 피부소양(皮膚瘙痒), 유즙불하(乳汁不下), 무월경(無月經) 등에 한방약재로 사용되어 왔다.The white matter is also called jjiljiji, the fruit of serialization herbace, the Latin name is Fructus trubuli. Zhigo, the plant of the origin of white zirconia, belongs to the Zygophyllaceae family, and its scientific name is Trubulus terrestris L. Baekji-ryeo has been traditionally used as a herbal medicine for headaches such as vertigo, moxibustion, skin sophistication, milk slack, and amenorrhea.

그러나 이와 같은 백출의 전통적인 효능과 본 발명의 피부 미백 효과와는 완전히 구별되는 것이다.However, it is completely distinguished from the traditional efficacy of such lightening and the skin lightening effect of the present invention.

한편 백질려 추출물이나 백질려와 관련되어 얻어진 물질을 바탕으로 전립선 비대증 치료(일본특허 JP92-169534), 피부염증치료(일본특허 JP91-190809), 방부 · 항염 · 해열 · 진통 · 이뇨제(SU78-633528), 동맥경화치료(SU77-567449)용으로 사용될 수 있음이 알려져 있으나 역시 본 발명과 완전히 구별된다.On the other hand, prostate hypertrophy treatment (Japanese Patent JP92-169534), dermatitis treatment (Japanese Patent JP91-190809), antiseptic, anti-inflammatory, antipyretic, analgesic, diuretic (SU78-633528) It is known that it can be used for atherosclerosis treatment (SU77-567449), but it is also completely distinguished from the present invention.

기존의 백출 성분 동정 연구에 의하면 디오스게닌(diosgenin), 트리뷸로사이드(tribuloside) 등의 플라보노이드(flavonoid)화합물들이 보고되어 있다.Existing studies of whitening components have reported flavonoid compounds such as diosgenin and tribuloside.

본 발명의 상기 백질려 추출물은 다음과 같은 과정을 통해 얻을 수 있다.The white chrysanthemum extract of the present invention can be obtained through the following process.

약재로 시판되는 백질려를 구입하여 탄소수 1~4개의 무수 또는 함수 저급알콜, 에틸아세테이트 또는 아세톤 등의 유기용매로 1차 추출한 후 감압농축하고, 동결건조하거나 분무건조하여 백질려 추출물을 얻을 수 있다.You can purchase white Zhijichi, which is sold as a medicine, and extract it first with an organic solvent such as anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, ethyl acetate or acetone. .

건조된 상기 백출 추출물을 쥐의 멜라노마 세포에 처리하였을 때, 매우 강력한 멜라닌 합성 저해효과를 나타내었다.When the dried baekchul extract was treated to mouse melanoma cells, it showed a very strong melanin synthesis inhibitory effect.

상기와 같이 얻어진 백출 추출물을 함유하는 피부외용연고나 로션같은 여러 화장료를 제조할 수 있으며, 이를 피부에 도포하였을 때 피부미백효과가 매우 우수한 것으로 나타났다.Various cosmetics such as skin ointment or lotion containing the white extract obtained as described above can be prepared, and when applied to the skin, the skin whitening effect is very excellent.

그리고 피부외용연고나 화장료 제조시에 백출 추출물의 함량을 0.001중량%이하의 농도로 함유시켰을 때에는 뚜렷한 피부미백효과를 기대할 수 없었고, 10중량%이상의 농도로 함유시켰을 때에는 함유량의 증가에 따라 뚜렷한 피부미백효과의 증가가 나타나지 않았으므로, 상기 백출 추출물의 함량을 건조 중량으로 0.001~10.0중량%로 함유시키는 것이 적당하고, 바람직하게는 0.01~5.0중량%로 함유시키는 것이 우수한 피부미백효과를 나타내었다.In addition, when the content of white extract was contained in the concentration of 0.001% by weight or less in the preparation of external skin ointment or cosmetics, a clear skin whitening effect could not be expected, and when contained in the concentration of 10% by weight or more, the skin was whitened with increasing content. Since there was no increase in the effect, it is appropriate to contain the content of the baekchul extract in a dry weight of 0.001 ~ 10.0% by weight, preferably containing 0.01 ~ 5.0% by weight showed an excellent skin whitening effect.

다음 실시예에 의거하여 본 발명을 자세히 설명하지만, 본 발명이 다음 실시예에만 한정되는 것이 아님을 밝혀둔다.Although the present invention will be described in detail based on the following examples, it should be understood that the present invention is not limited only to the following examples.

실시예 1.Example 1.

백질려의 분쇄물 300g을 80%메탄올 용액 3L에 넣고, 냉각콘덴서가 달린 환류 추출기에서 3시간 끓여 추출한 다음, 300메쉬 여과포로 여과한 후 잔사를 같은 방법으로 1회 더 추출하였다. 추출액을 합하여 상온에서 화트만(Whatman) 2번 여과지로 여과하여 불용성 물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압 농축한 후 동결건조하여 건조 중량 17g을 얻었다.300 g of the white crushed powder was added to 3 L of 80% methanol solution, boiled for 3 hours in a reflux extractor equipped with a cooling capacitor, filtered through a 300 mesh filter cloth, and the residue was extracted once more in the same manner. The combined extracts were filtered using Whatman No. 2 filter paper at room temperature to remove insoluble materials, concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser, and lyophilized to obtain a dry weight of 17 g.

실시예 2.Example 2.

백질려의 분쇄물 300g을 정제수 3L에 넣고, 실시예 1과 동일한 방법으로 실시하여 건조중량 22g을 얻었다.300 g of crushed granules were placed in 3 L of purified water, and the same procedure as in Example 1 was carried out to obtain a dry weight of 22 g.

실시예 3.Example 3.

백질려의 분쇄물 300g을 85% 에탄올 용액 3L에 넣고, 실시예 1과 동일한 방법으로 실시하여 건조중량 18g을 얻었다.300 g of crushed white bread was placed in 3 L of a 85% ethanol solution, and the same procedure as in Example 1 was carried out to obtain a dry weight of 18 g.

실시예 4.Example 4.

백질려의 분쇄물 300g을 70% 아세톤 용액 3L에 넣고, 실시예 1과 동일한 방법으로 실시하여 건조중량 22g을 얻었다.300 g of crushed white bread was placed in 3 L of a 70% acetone solution, and the same method as in Example 1 was carried out to obtain a dry weight of 22 g.

실시예 5.Example 5.

백질려의 분쇄물 300g을 50% 에탄올 용액 3L에 넣고, 실시예 1과 동일한 방법으로 실시하여 건조중량 22g을 얻었다.300 g of crushed white bread was added to 3 L of a 50% ethanol solution, and the same method as in Example 1 was carried out to obtain a dry weight of 22 g.

실시예 6.Example 6.

백질려의 분쇄물 300g을 60% 메탄올 용액 3L에 넣고, 실시예 1과 동일한 방법으로 실시하여 각각의 건조중량 19g을 얻었다.300 g of crushed white bread was placed in 3 L of a 60% methanol solution, and the same method as in Example 1 was carried out to obtain 19 g of each dry weight.

실시예 7.Example 7.

백질려의 분쇄물 300g을 포화 노말부탄올용액 3L에 넣고, 실시예 1과 동일한 방법으로 실시하여 건조중량 17g을 얻었다.300 g of crushed granules were placed in 3 L of saturated normal butanol solution, and the same procedure as in Example 1 was carried out to obtain a dry weight of 17 g.

실시예 8.Example 8.

백질려의 분쇄물 300g을 클로로포름용액 3L에 넣고, 실시예 1과 동일한 방법으로 실시하여 건조중량 15g을 얻었다.300 g of a white crushed powder was put in 3 L of chloroform solution, and the same method as in Example 1 was carried out to obtain a dry weight of 15 g.

실험예 1.Experimental Example 1.

상기 실시예 1~8에 따라 얻어진 각 추출물들을 쥐의 멜라노마 세포의배양액에 첨가하여 세포수준에서의 미백 효과를 실험하였다(Lotan R., Lotan D. Cancer Res. 40:3345~3350, 1980). 실시예 1~8에 따라 얻어진 각 추출물들을 최종농도가 0.1%가 되도록 하여 하이드로퀴논 수용액과 함께 각각 B-16멜라노마 세포의 배양배지에 첨가하여 3일간 배양한 후 세포들을 트립신처리하여 배양용기로부터 떼어내 원심분리한 후 멜라닌을 추출하였다. 이것에 수산화나트륨 용액(1N 농도) 1ml를 가하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용하여 400나노미터에서 흡광도을 측정하여 생성된 멜라닌의 양을 단위 세포수당(106 cell)의 흡광도로 나타내는 방법으로 수행하였으며, 대조군에 대한 상대적인 멜라닌 생성량을 저해율(%)로 계산하고 결과를 하기 표 1에 정리하였다. 여기서 멜라닌생성량과 저해율은 3번 반복 실험한 값이다.Each of the extracts obtained according to Examples 1 to 8 was added to the culture medium of the melanoma cells of mice to test the whitening effect at the cellular level (Lotan R., Lotan D. Cancer Res. 40: 3345-3350, 1980). . Each of the extracts obtained according to Examples 1 to 8 were added to a culture medium of B-16 melanoma cells with hydroquinone aqueous solution, respectively, in a final concentration of 0.1%, followed by incubation for 3 days, and then cells were trypsinized from the culture vessel. The melanin was extracted after centrifugation. To which the added sodium hydroxide solution (1N concentration) 1ml hydroxide dissolved melanin boiled 10 minutes using a spectrophotometer in a manner that indicates the amount of the produced melanin in heupgwangdoeul measured at 400 nanometers to the absorbance of the unit cell allowance (10 6 cell) The melanin production relative to the control group was calculated as inhibition rate (%) and the results are summarized in Table 1 below. Melanin production and inhibition rate are the values of three repeated experiments.

[표 1]TABLE 1

백질려 추출물의 세포수준에서의 멜라닌 생성 저해효과Inhibitory Effect of Bacillus chinensis Extract on Cell Level

Figure pat00010
Figure pat00010

상기 표 1의 결과에서 볼 수 있듯이, 실시예 1~8에 따라 얻어진 각 시료들은 전혀 정제되지 않은 추출물임을 감안하면 기존에 알려진 미백물질인 하이드로퀴논과 비교할 때 배양된 쥐의 멜라노마 세포에 대하여 매우 강력한 멜라닌 생성 억제능이 있음을 알 수 있다.As can be seen from the results of Table 1, considering that each sample obtained according to Examples 1 to 8 is not an extract that is not purified at all, compared to the hydroquinone of the previously known whitening substance hydroquinone for the cultured mouse melanoma cells It can be seen that there is a strong melanin production inhibitory ability.

실험예 2.Experimental Example 2.

상기 실험예 1과 같은 방법으로 배양된 쥐의 멜라노마 세포에 대하여 실시예 1의 추출물에 대하여 농도에 따른 멜라닌 생성 억제능을 조사하였으며 결과는 하기 표 2와 같다.Melamine production of rats cultured in the same manner as in Experimental Example 1 was investigated for the melanin production inhibitory ability according to the concentration of the extract of Example 1 and the results are shown in Table 2.

[표 2]TABLE 2

백질려 추출물의 세포수준에서의 멜라닌 생성 저해효과Inhibitory Effect of Bacillus chinensis Extract on Cell Level

Figure pat00011
Figure pat00011

상기 표 2의 결과에서 볼 수 있듯이, 백질려 추출물은 배양된 쥐의 멜라노마 세포에 대하여 매우 강력한 멜라닌 생성 억제능을 가지고 있음을 알 수 있다. 하이드로퀴논은 저농도에서 강력한 멜라닌 생성 억제능을 가지지만 세포 독성이 심해 0.0001%이상에서는 실험을 할 수 없는 것에 반하여, 백질려 추출물은 1%농도에서 세포독성을 나타내지 않으면서도 하이드로퀴논보다 높은 멜라닌 생성 억제 효과를 갖는다. 또한 백질려 추출물이 단일물질이 아니고 혼합물질이라는 것을 고려할 때 매우 높은 멜라닌 생성 억제능을 가지고 있으므로, 기미나 주근깨 개선 또는 피부 미백에 매우 유용하게 사용될 수 있다.As can be seen from the results in Table 2, the white bran extract has a very strong melanin production inhibitory ability against the cultured melanoma cells. Hydroquinone has strong melanin production inhibitory ability at low concentrations, but the cytotoxicity is so severe that it cannot be tested at more than 0.0001%, whereas the extract of Bacillus vulgaris has higher melanin production inhibitory effect than hydroquinone without showing cytotoxicity at 1% concentration. Has In addition, since white extract has a very high melanin inhibitory ability, considering that it is not a single substance but a mixture, it can be very useful for improving freckles and freckles or skin whitening.

이하 백질려 추출물을 함유하는 화장료의 처방예를 제조예에 의해 나타내었다.Hereinafter, the preparation example of the cosmetics containing an extract of whitening is shown by the preparation example.

제조예 1 및 비교예 1Preparation Example 1 and Comparative Example 1

백질려 추출물을 함유하는 피부 외용연고 처방으로 다음 표 3과 같이 하였다. 여기서 백질려 추출물은 상기 실시예 7의 것을 말한다.Skin ointment formulation containing whitening extract was as shown in Table 3. Here, the extract of Echinacea refers to that of Example 7.

[표 3]TABLE 3

Figure pat00012
Figure pat00012

제조예 2 및 비교예 2Preparation Example 2 and Comparative Example 2

백질려 추출물을 함유하는 화장료 중 크림의 처방으로 다음 표 4와 같이 하였다. 여기서 백질려 추출물은 상기 실시예 7의 것을 말한다.As a prescription of the cream in the cosmetic composition containing the extract of Baekilgi as shown in Table 4 below. Here, the extract of Echinacea refers to that of Example 7.

[표 4]TABLE 4

Figure pat00013
Figure pat00013

제조예 3 및 비교예 3Preparation Example 3 and Comparative Example 3

백질려 추출물을 함유하는 화장료 중 유연화장수의 처방으로 다음 표 5와 같이 하였다. 여기서 백질려 추출물은 상기 실시예 7의 것을 말한다.Formulation of flexible cosmetics in cosmetics containing the extract of Baekilji was as shown in Table 5. Here, the extract of Echinacea refers to that of Example 7.

[표 5]TABLE 5

Figure pat00014
Figure pat00014

제조예 4 및 비교예 4Preparation Example 4 and Comparative Example 4

백질려 추출물을 함유하는 화장료 중 영양화장수의 처방으로 다음 표 6과 같이 하였다. 여기서 백질려 추출물은 상기 실시예 7의 것을 말한다.Formulation of nutritional longevity among cosmetics containing the extract of Baekilji was as shown in Table 6. Here, the extract of Echinacea refers to that of Example 7.

[표 6]TABLE 6

Figure pat00015
Figure pat00015

제조예 5 및 비교예 5Preparation Example 5 and Comparative Example 5

백질려 추출물을 함유하는 화장료 중 팩의 처방으로 다음 표 7과 같이 하였다. 여기서 백질려 추출물은 상기 실시예 7의 것을 말한다.The formulation of the pack of cosmetics containing the extract of Baekilji was as shown in Table 7. Here, the extract of Echinacea refers to that of Example 7.

[표 7]TABLE 7

Figure pat00016
Figure pat00016

제조예 6 및 비교예 6Preparation Example 6 and Comparative Example 6

백질려 추출물을 함유하는 화장료 중 엣센스의 처방으로 다음 표 8과 같이 하였다. 여기서 백질려 추출물은 상기 실시예 7의 것을 말한다.Formulation of the essence of the cosmetics containing the extract of Baekilgi as shown in Table 8 below. Here, the extract of Echinacea refers to that of Example 7.

[표 8]TABLE 8

Figure pat00017
Figure pat00017

실험예 3.Experimental Example 3.

건강한 남녀 20명을 선정하여 양팔의 하박부에 직경 7㎜크기의 구멍이 6개씩 2줄로 파인 알루미늄 호일을 붙이고, 팔에서 10cm떨어진 거리에서 ORIEL solar simulator 1000W를 사용하여 60mJ/cm2의 광량을 조사하였다. 이때 조사전에 70%에탄올 수용액으로 조사부위를 잘 세척하였다. 조사하기 3일전부터 조사 후 3주째까지 1일 2회씩 제조예 1~6 및 비교예 1~6에 따라 제조된 백질려 추출물을 함유한 시료와 백질려 추출물이 함유되지 않은 기제를 한 쌍으로 같은 줄에 도포하였다. 제조예 5 및 비교예 5의 팩 처방의 경우 도포한 다음 15분 후에 떼어내었다. 각각에 대하여 제조예와 비교예의 색소침착도를 육안으로 판정하고, 제조예가 비교예에 비해 색소침착을 억제한 정도를 뚜렷한 효과, 효과있음, 차이없음의 3단계로 평가하였으며, 그 결과는 하기 표 9와 같다.Twenty healthy men and women were selected to attach aluminum foil with two rows of 6 holes with a diameter of 7 mm in the lower part of both arms and irradiated with 60mJ / cm 2 light using ORIEL solar simulator 1000W at a distance of 10cm from the arm. It was. At this time, the irradiation site was well washed with 70% ethanol aqueous solution before irradiation. Twice a day from 3 days before irradiation to 3 weeks after irradiation, the same sample was prepared in pairs of the sample containing the white chlorosis extract prepared according to Preparation Examples 1 to 6 and Comparative Examples 1 to 6 and the base containing no white chlorosis extract. It was applied to a string. The pack formulations of Preparation Example 5 and Comparative Example 5 were removed 15 minutes after application. For each, the pigmentation degree of the preparation example and the comparative example was visually determined, and the degree of suppression of the pigmentation of the preparation example compared to the comparative example was evaluated in three stages of distinct effects, effects, and no differences, and the results are shown in the following table. Same as 9.

[표 9]TABLE 9

Figure pat00018
Figure pat00018

상기 표 9의 결과에서 볼 수 있듯이, 제조예 1~6에 따라 제조된 백질려 추출물 함유 연고 및 화장료는 피시험자 20명 중에서 최소 10명 이상에 대하여 미백효과를 나타내었으며, 특히 많은 양의백질려 추출물이 적용된 제조예 1과 비교예 1의 비교실험에서는 35%가 뚜렸한 색소 침착 저해 효과를 보이고, 피부내에서 어떤 부작용도 나타나지 않아, 백질려 추출물이 안전하고 효과가 매우 뛰어난 기미나 주근깨 개선 또는 피부미백제임을 알 수 있다.As can be seen from the results of Table 9, the ointment and cosmetics containing the white bran extract prepared according to Preparation Examples 1 to 6 showed a whitening effect on at least 10 or more among 20 subjects, in particular, a large amount of white itch In the comparative experiments of Preparation Example 1 and Comparative Example 1 to which the extract was applied, 35% showed a rich pigmentation inhibitory effect, and no side effects appeared in the skin. It can be seen that it is a skin lightening agent.

상술한 바와 같이 백질려 추출물이 멜라닌 합성을 억제하는 효과와 피부자극이 없는 안정한 물질임을 발견하여 이를 함유한 피부미백용 연고나 화장료로 사용할 수 있게 된다.As described above, the whitening extract is found to be a stable substance without inhibiting melanin synthesis and skin irritation, and thus can be used as an ointment or cosmetic for skin whitening containing the same.

Claims (2)

백질려 추출물을 유효성분으로 하는 피부미백용 조성물.Skin whitening composition using the extract as an active ingredient. 제 1 항에 있어서, 상기 백질려 추출물이 건조 중량으로 0.001~10.0중량% 함유된 것을 특징으로 하는 피부미백용 조성물.The composition for skin whitening according to claim 1, wherein the whitening extract is contained in an amount of 0.001 to 10.0% by weight.
KR1019970066969A 1997-12-09 1997-12-09 Composition for skin whitening KR100466379B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019970066969A KR100466379B1 (en) 1997-12-09 1997-12-09 Composition for skin whitening

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019970066969A KR100466379B1 (en) 1997-12-09 1997-12-09 Composition for skin whitening

Publications (2)

Publication Number Publication Date
KR19990048306A KR19990048306A (en) 1999-07-05
KR100466379B1 true KR100466379B1 (en) 2005-07-11

Family

ID=37303328

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970066969A KR100466379B1 (en) 1997-12-09 1997-12-09 Composition for skin whitening

Country Status (1)

Country Link
KR (1) KR100466379B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100604073B1 (en) * 1999-09-14 2006-07-24 주식회사 엘지생활건강 Cosmetic composition containing one selected from panax notoginseng extract, cucumis melo extract and dendrobium moniliforme extract
KR101589119B1 (en) 2015-04-09 2016-01-28 김인숙 Cosmetic composition of skin-whitening components for lowering the face -temperature and the method of preparing the same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100564227B1 (en) * 1999-09-21 2006-03-28 주식회사 엘지생활건강 Cosmetic material composition for skin whitening
KR20030003670A (en) * 2001-03-24 2003-01-10 주식회사 메덱스바이오 Antagonistic Compositions Against Dioxin-like Compounds Comprising Extract of Tribulus terrestris L.
KR20030076829A (en) * 2002-03-22 2003-09-29 한완석 Cosmetics composition for beautiful white skins, removal of chitins, removal of acnes, removal of black mushrooms
KR100848213B1 (en) * 2007-03-23 2008-07-24 주식회사한국신약 Tribulus terrestris l. extract having growth hormone secretion accelerating function

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03190809A (en) * 1989-12-21 1991-08-20 Shiseido Co Ltd Skin external preparation
US5466452A (en) * 1991-02-28 1995-11-14 Phytopharm Ltd. Pharmaceutical compositions for the treatment of skin disorders
JPH09255551A (en) * 1996-03-28 1997-09-30 Shiseido Co Ltd Skin preparation for external use
KR101070113B1 (en) * 2005-04-27 2011-10-05 주식회사 케이티 System for making a design and management of communication facilities
KR101080862B1 (en) * 2010-02-03 2011-11-07 (주)송도텔레콤 System and method for REST style Third Party Call API
KR101082907B1 (en) * 2004-02-18 2011-11-11 삼성전자주식회사 Back light assembly and liquid crystal display having the same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03190809A (en) * 1989-12-21 1991-08-20 Shiseido Co Ltd Skin external preparation
US5466452A (en) * 1991-02-28 1995-11-14 Phytopharm Ltd. Pharmaceutical compositions for the treatment of skin disorders
JPH09255551A (en) * 1996-03-28 1997-09-30 Shiseido Co Ltd Skin preparation for external use
KR101082907B1 (en) * 2004-02-18 2011-11-11 삼성전자주식회사 Back light assembly and liquid crystal display having the same
KR101070113B1 (en) * 2005-04-27 2011-10-05 주식회사 케이티 System for making a design and management of communication facilities
KR101080862B1 (en) * 2010-02-03 2011-11-07 (주)송도텔레콤 System and method for REST style Third Party Call API

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100604073B1 (en) * 1999-09-14 2006-07-24 주식회사 엘지생활건강 Cosmetic composition containing one selected from panax notoginseng extract, cucumis melo extract and dendrobium moniliforme extract
KR101589119B1 (en) 2015-04-09 2016-01-28 김인숙 Cosmetic composition of skin-whitening components for lowering the face -temperature and the method of preparing the same

Also Published As

Publication number Publication date
KR19990048306A (en) 1999-07-05

Similar Documents

Publication Publication Date Title
JPH07187989A (en) Extracted solution of perilla frutescens and skin-beautifying cosmetic containing the same
KR100604073B1 (en) Cosmetic composition containing one selected from panax notoginseng extract, cucumis melo extract and dendrobium moniliforme extract
KR100544024B1 (en) Skin whitening compound
KR100466379B1 (en) Composition for skin whitening
KR100190993B1 (en) Water soluble fraction extracts of asparagus cochinchinensis having improved skin whitening defects by removing darkening components and a composition for improving freckles and skin whitening containing thereof
KR100190992B1 (en) A skin whitening composition containing extracts of asparagus cochinchinensis and tyrosinase inhibitor
JP4772190B2 (en) Skin lightening agent
KR100546735B1 (en) Skin Whitening Composition
KR100789632B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20050092313A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR20020029182A (en) Cosmetic composition containing Veratrum nigrum L. extracts and Potentilla chinensis Ser. extracts
KR100453217B1 (en) Skin whitener
KR100789634B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR19990048305A (en) Skin Whitening Composition
KR20020029181A (en) Cosmetic composition containing Liquidambar taiwaniana Hance extracts and Cynanchum atratum Bunge extracts
KR100585468B1 (en) Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper
KR100789635B1 (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100190989B1 (en) Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof
KR100789631B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR20050092314A (en) Skin whitening cosmetic containing a herb extract with inhibitory activity of melanin formation
KR20010035445A (en) Composition containing extracts from dried roots of Trichosantes kirilowii maxim for external application and skin-whitening and process for preparation thereof
KR20040059005A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR20040059007A (en) Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation
KR100724168B1 (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR100562369B1 (en) Cosmetic composition containing extracts of Cortex Hibisci, Resina Liquidambaris or Hypericum chinese L.

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121221

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20131230

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20141226

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20151229

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20161227

Year of fee payment: 13

EXPY Expiration of term